NCT03415126 - A Study of ASN007 in Patients With Advanced Solid Tumors | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 19, 2018

Primary Completion Date

June 30, 2020

Study Completion Date

June 30, 2020

Conditions

CancerMalignancyNeoplasiaNeoplasmNeoplasm MetastasisColon CancerColonic NeoplasmsColon Cancer Liver MetastasisMetastatic CancerMetastatic MelanomaMetastatic Colon CancerMetastatic Lung CancerNon Small Cell Lung Cancer MetastaticPancreatic CancerPancreas CancerPancreas AdenocarcinomaPancreas NeoplasmMetastatic Nonsmall Cell Lung CancerMetastatic Pancreatic Cancer

Interventions

DRUG

ASN007: ascending doses

Oral drug for the treatment of advanced solid tumors

DRUG

ASN007 RD

Oral drug for the treatment of advanced solid tumors

Trial Locations (5)

33612

H. Lee Moffitt Cancer Center, Tampa

77030

MD Anderson Cancer Center, Houston

78229

South Texas Accelerated Research Therapeutics, San Antonio

78240

NEXT Oncology, San Antonio

02114

Massachusetts General Hospital, Boston